Acessibilidade / Reportar erro

Experimental comparative study of bioactive composite with polymeric matrix for applications to oculoplastic surgery for tissue replacement

PURPOSE: To compare two new biomaterials: Composite 10% (Engineering School - Universidade Federal de Minas Gerais - UFMG - Brazil) and Composite 20% (Engineering School - Universidade Federal de Minas Gerais - UFMG - Brazil), with two similar materials as control: MedporTM (Porex Surgical Inc. - USA) e PoliporeTM (Homus Com. Ind. Ltda - BRASIL). METHODS: In vivo randomized experimental double blind study: a transconjunctival approach was performed in both cartilaginous superior orbital walls of 28 rabbits for 56 implants divided into 4 groups: GI: Composite 10%/MedporTM; GII: Composite 10%/PoliporeTM; GIII: Composite 20%/MedporTM; GIV: Composite 20%/PoliporeTM. The mean rate for implant time of permanence was 19.7 weeks. The Student's t test was used for statistical analysis. RESULTS: Revealed similar biocompatibility of all materials and none of the implants was extruded; one Composite 20% had partial exposure. Histomorphometry showed a greater bioactivity of the composites with significantly thicker fibrous encapsulation, with more collagen and fibroblasts, exuberant angiogenesis, and a lower inflammatory cell mean compared to controls. The presence of precipitation of a hydroxycarbonate apatite layer, which acts as an implant-tissue bond was confirmed. Composites presented a smaller tissular invasion index of the pores compared to controls. CONCLUSIONS: The composites showed a good biocompatibility and some additional advantageover the MedporTM and PoliporeTM controls.

Surgery, plastic; Composite resins; Biocompatible materials; Prostheses and Implants; Inflammation; Tissue adhesives; Randomized Controlled Trial [Publication Type]; Rabbits; Comparative study


Conselho Brasileiro de Oftalmologia Rua Casa do Ator, 1117 - cj.21, 04546-004 São Paulo SP Brazil, Tel: 55 11 - 3266-4000, Fax: 55 11- 3171-0953 - São Paulo - SP - Brazil
E-mail: abo@cbo.com.br